David McClung - 08 Dec 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: Chief Financial Officer
Signature: /s/ David McClung
Issuer symbol: BCDA
Transactions as of: 08 Dec 2025
Transactions value $: $120,033
Form type: 4
Filing time: 10 Dec 2025, 21:54:29
Previous filing: 02 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
McClung David	Chief Financial Officer	C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE	/s/ David McClung	10 Dec 2025	0001686155

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Award	$79.8K	+58.3K	+121.53%	$1.37	106K	08 Dec 2025	Direct	F1
transaction	BCDA	Common Stock	Tax liability	$40.2K	+29.3K	+61.7%	$1.37	76.9K	08 Dec 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA	Stock Option (right to buy)	Award	$0	+27K	+139.61%	$0.00	46.3K	08 Dec 2025	Common stock	20K	$1.37	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025.
F2	The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person.
F3	The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.